Fig. 24From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseA representative model for interaction of compound C16 and the AChE [46]Back to article page